Xitong Geng

Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A cross-ancestry genetic atlas of shared susceptibility between infectious diseases and cancer.

A cross-ancestry genetic atlas of shared susceptibility between infectious diseases and cancer.

Journal: Functional & integrative genomics

Published: April 24, 2026

Identification of the immune-related diagnostic biomarkers between Graves' disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning.

Identification of the immune-related diagnostic biomarkers between Graves' disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning.

Journal: Autoimmunity

Published: February 23, 2026

A Tumor Microenvironment-Derived CAF-VEGF Model and Its Application in Biomarker Screening for HCC.

A Tumor Microenvironment-Derived CAF-VEGF Model and Its Application in Biomarker Screening for HCC.

Journal: Cell biochemistry and function

Published: September 15, 2025

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Journal: Gene

Published: November 26, 2024

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

Journal: Journal of inflammation research

Published: October 08, 2024

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

Journal: Aging

Published: December 05, 2023

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.

Journal: Journal of hepatocellular carcinoma

Published: November 30, 2023

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Journal: Aging

Published: November 14, 2023

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

Journal: Aging

Published: August 20, 2023

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Journal: Aging

Published: April 03, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026